TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,151 JPY | -0.34% |
|
-1.28% | +2.39% |
| May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
| May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 41.69B | ||||||
| 693B | ||||||
| 584B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B |
